Healthcare

Image

Global Digital Pathology Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Oct 2022
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Digital Pathology Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR - % Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 971.49 Million
Diagram Market Size (Forecast Year) USD 2492.64 Million
Diagram CAGR %

Global Digital Pathology Market, By Type (Human Pathology, Veterinary Pathology), Product (Artificial Intelligence, Scanners, Software, Communication Systems, Storage Systems), Application (Drug Discovery, Disease Diagnosis, Teleconsultation, Training and Education), End Users (Pharmaceutical and Biotechnology, Hospitals, Academic Research Institutes) – Industry Trends and Forecast to 2029.

 Digital Pathology Market Analysis and Size

The use of this disruptive technology is on the verge of becoming standard of care in the field of pathology. Static images, live streaming images, and, most recently, whole slide imaging have all been used in digital pathology (WSI). Digital pathology devices or image analysis algorithms used in diagnostic reporting typically require regulatory approval such as FDA (USA) or CE IVD. Digital pathology and image analysis could improve the accuracy, reproducibility, and standardisation of study inclusion criteria and outcomes.

Data Bridge Market Research analyses that the digital pathology market which was USD 971.49 million in 2021, is expected to reach USD 2,492.64 million by 2029, at a CAGR of 12.5% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Digital Pathology Market Scope and Segmentation  

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Type (Human Pathology, Veterinary Pathology), Product (Artificial Intelligence, Scanners, Software, Communication Systems, Storage Systems), Application (Drug Discovery, Disease Diagnosis, Teleconsultation, Training and Education), End Users (Pharmaceutical and Biotechnology, Hospitals, Academic Research Institutes)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

F. Hoffmann-La Roche Ltd (Switzerland), Hamamatsu Photonics (Japan), 3DHISTECH Ltd. (Hungary), AstraZeneca (U.K.), General Electric (U.S.), Healthcare Trading Co. LLC (UAE), Koninklijke Philips N.V (Netherlands), Inspirata, Inc. (U.S.), Olympus Corporation (Japan), Sectra AB (U.S.), PerkinElmer Inc. (U.S.), Apollo Enterprise Imaging Corp (U.S.), Mikroscan Technologies, Inc. (U.S.), VMscope GmbH (Germany), Huron Technologies International Inc. (Canada), Objective Pathology Services Limited (Canada), OptraScan (U.S.), Pathcore (Canada), Agfa-Gevaert Group (Belgium), Proscia Inc. (U.S.)

Market Opportunities

  • Rising use of AI in healthcare is increasing
  •  Growing emphasis on improving patient care quality by incorporating AI into various aspects of healthcare services

Market Definition

Digital pathology is the practise of pathology that employs digital imaging. Digital pathology is the use of computer workstations to view digital whole slide images (WSIs) obtained from high resolution scanning of glass microscope slides applications include teaching, research and primary diagnostic reporting.

Global Digital Pathology Market Dynamics

Drivers

  • Rapid technological advancements are fostering the market growth

Rapid technological advancements in digital pathology systems are also expected to drive market expansion. Digital imaging, computerization, robotic light microscopy, and multiple fibre optic communications are all contributing to the expansion. Whole slide imaging is one such technique that has several advantages over conventional light microscopes and is expected to boost the market.

  • Rising use of AI in healthcare

The use of AI in healthcare is increasing, with a growing emphasis on improving patient care quality by incorporating AI into various aspects of healthcare services, such as pathological diagnosis. As a result, artificial intelligence (AI) provides smooth primary care flow and automation, allowing doctors to focus on more essential and horrific patients. Furthermore, AI solutions in the healthcare industry are becoming more humanized.

Opportunities

  • Growing preference for computer-aided diagnosis

The growing preference for computer-aided diagnosis, which integrates image processing, physics, mathematics, and computing algorithms, enables efficient disease detection, and aids in the evaluation of anatomic structures of interest, as well as the quantification of disease progression and risk assessment, will drive market growth. Companies such as Olympus are providing a variety of tools for remote slide sharing and image processing, which is expected to drive market growth in the coming years. Leica Biosystems received FDA approval for the Aperio AT2 DX Scanner and Aperio WebViewer for remote diagnosis during the pandemic in April 2020. During this emergency, Phillips also received FDA approval for its IntelliSite Pathology Solution for remote diagnosis.

Restraints/Challenges

  • High cost of digital pathology

High cost of digital pathology and the low adoption rate in emerging and underdeveloped countries will obstruct the market's growth rate. Augmenting keeps the cost of digital pathology low by functioning as a modular hardware platform with integrated digital pathology software applications.

This digital pathology market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the digital pathology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Digital Pathology Market

The COVID-19 pandemic had a significant impact on digital pathology services. Digital pathology has the potential to "protect clinical services and pathology-based research in the current and future climates. This digital-based diagnostic approach represents a new approach to evaluating surgical pathology slides from formalin-fixed paraffin-embedded tissue (FFPE). It liberates the pathologist from the constraints of working with an optical microscope in his or her office. At the same time, it can have an impact on pathologists “social interaction,' including their interactions with clinicians and even patients. At the peak of the COVID-19 pandemic, a recent contribution from our group briefly addressed the changing aspects of such a relationship.

Recent developments

  • On September 2, 2021, Visiopharm (Denmark) and Agilent Technologies, Inc. (US) collaborated to co-market Visiopharm's portfolio of CE-IVD marked AI-driven Precision Pathology software and Agilent's portfolio of automated pathology staining solutions. Based on a shared vision of end-to-end quality and standardisation of tissue diagnostics, the alliance will address the unmet needs of pathology laboratories around the world. The companies' shared goal is to create technology, products, and services that will improve pathology lab uniformity and speed up correct diagnosis.
  • In April 2021, OptraSCAN will introduced OS-Ultra 320 high-speed scanners. The device is designed to scan cells/tissues 15x15 mm in size at 40x magnification in 60 seconds. Furthermore, the widespread use of scanners in pathology labs is propelling market growth.

Global Digital Pathology Market Scope

The digital pathology market is segmented on the basis of type, product, application and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Human Pathology
  • Veterinary Pathology

Product 

  • Scanners
  • Brightfield
  • Other Scanners
  • Software
  • Integrated software
  • Standalone software
  • Storage Solution

Application 

  • Drug Discovery
  • Disease Diagnosis
  • Training and Education

End users

  • Academic and Research Institutes
  • Hospitals and Reference Laboratories
  • Pharmaceutical and Biotechnology Companies

Digital Pathology Market Regional Analysis/Insights

The digital pathology market is analysed and market size insights and trends are provided by country, type, product, application and end users as referenced above.

The countries covered in the digital pathology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the digital pathology market due to introduction of favourable reimbursement policies and the implementation of favourable initiatives by the government in the U.S. and Canada.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the rising prevalence of cancer diseases in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The digital pathology market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital pathology market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the digital pathology market. The data is available for historic period 2010-2020.

Competitive Landscape and Digital Pathology Market Share Analysis

The digital pathology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to digital pathology market.

Some of the major players operating in the digital pathology market are:

  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Hamamatsu Photonics (Japan)
  • 3DHISTECH Ltd. (Hungary)
  • AstraZeneca (U.K.)
  • General Electric (U.S.)
  • Healthcare Trading Co. LLC (UAE)
  • Koninklijke Philips N.V (Netherlands)
  • Inspirata, Inc. (U.S.)
  • Olympus Corporation (Japan)
  • Sectra AB (U.S.), PerkinElmer Inc. (U.S.)
  • Apollo Enterprise Imaging Corp (U.S.)
  • Mikroscan Technologies, Inc. (U.S.)
  • VMscope GmbH (Germany)
  • Huron Technologies International Inc. (Canada)
  • Objective Pathology Services Limited (Canada)
  • OptraScan (U.S.)
  • Pathcore (Canada)
  • Agfa-Gevaert Group (Belgium)
  • Proscia Inc. (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Digital Pathology Market is projected to grow at a CAGR of 12.5% during the forecast period by 2029.
The future market value of the Digital Pathology Market is expected to reach USD 2,492.64 million by 2029.
The major players in the Digital Pathology Market are F. Hoffmann-La Roche Ltd (Switzerland), Hamamatsu Photonics (Japan), 3DHISTECH Ltd. (Hungary), AstraZeneca (U.K.), General Electric (U.S.), Healthcare Trading Co. LLC (UAE), Koninklijke Philips N.V (Netherlands), Inspirata, Inc. (U.S.), Olympus Corporation (Japan), Sectra AB (U.S.), etc.
The country covered in the Digital Pathology Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, etc.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials